Alpha Crest Capital Management LLC Innoviva, Inc. Transaction History

Alpha Crest Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $1.87 Million - $2.45 Million	161,118 New	161,118 $1.87 Million
Q2 2021 Aug 12, 2021	SELL	$11.45 - $13.96 $184,654 - $225,132	-16,127 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$11.06 - $12.87 $178,364 - $207,554	16,127 New	16,127 $193,000
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $298,457 - $399,222	-31,989 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.33 - $14.49 $149,671 - $209,945	14,489 Added 82.79%	31,989 $334,000
Q2 2020 Aug 12, 2020	BUY	$11.49 - $15.26 $201,075 - $267,050	17,500 New	17,500 $245,000
Q4 2019 Feb 12, 2020	SELL	$10.28 - $14.38 $767,916 - $1.07 Million	-74,700 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$10.05 - $14.55 $381,900 - $552,900	38,000 Added 103.54%	74,700 $787,000
Q2 2019 Aug 12, 2019	SELL	$13.1 - $14.95 $145,410 - $165,945	-11,100 Reduced 23.22%	36,700 $534,000
Q1 2019 May 10, 2019	BUY	$13.69 - $20.06 $78,033 - $114,341	5,700 Added 13.54%	47,800 $671,000
Q4 2018 Feb 11, 2019	BUY	$13.96 - $18.26 $587,716 - $768,746	42,100 New	42,100 $735,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.